The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Relief System for Adverse Drug Reactions in Korea

의약품 부작용 피해구제 제도

  • Yang, Min-Suk (Division of Allergy and Clinical Immunology, Department of Internal Medicine, SMG-SNU Boramae Medical Center)
  • 양민석 (서울특별시 보라매병원 알레르기내과)
  • Published : 2018.02.01
⟨ Previous Next ⟩

Abstract

The relief system for adverse drug reactions is a reimbursement system for non-fault injury from drugs that started with the intent of relieving victims of adverse drug reactions despite normal use of the medicines. In Korea, the relief system for adverse drug reactions started on December 19, 2014. To date, the deliberation process for 100 cases of adverse drug reactions has ended, of which 78 cases received relief reimbursement. As this is the early phase of system implementation, efforts to stabilize the system are needed. It is very important for clinicians to participate actively in mediating between the victims of adverse drug reactions and the Korea Institute of Drug Safety & Risk Management, to establish an effective relief system. It is also important to implement the most favorable relief system considering the socioeconomic and medical environment in Korea.

Keywords

References

  1. Kim MY, Yang MS, Kang HR, Cho SH, Min KU. Analysis of drugs causing severe cutaneous adverse reactions, based on the Korean database of spontaneously reported adverse drug reactions. Korean J Med 2014;86:710-721. https://doi.org/10.3904/kjm.2014.86.6.710
  2. Korea Institute of Drug Safety & Risk Management. Regional pharmacovigilance center [Internet]. Anyang (KR): Korea Institute of Drug Safety & Risk Management, c2018 [cited 2018 Jan 10]. Available from: https://www.drugsafe.or.kr/iwt/ds/ko/community/EgovCenterGuide.do.
  3. Lee DK. Rare disease to 4-year-old-child after taking cold medicine... Who is responsible? [Internet]. Seoul (KR): MBC news, c2018 [cited 2018 Jan 10]. Available from: http://imnews.imbc.com/replay/2017/nwdesk/article/4485352_21408.html.
  4. Yang MS, Kang HR, Kwon KH, et al. Improvement of operational procedure in relief system for adverse drug reaction. Cheongju (KR): National Institute of Food and Drug Safety Evaluation, 2016.
  5. Korea Institute of Drug Safety & Risk Management. Relief program for adverse drug reaction [Internet]. Anyang (KR): Korea Institute of Drug Safety & Risk Management, c2018 [cited 2018 Jan 10]. Available from: http://karp.drugsafe.or.kr/frt/cnt/EgovFrontView.do?bbsId=BBSMSTR_000000000231&nttId=116&bbsTyCode=BBST01&bbsAttrbCode=BBSA04.
  6. Suh HS, Park JE, Bae MS, et al. Research on the relief system for adverse drug reaction and its management plan. Cheongju (KR): Ministry of Food and Drug Safety, 2012.
  7. Pharmaceuticals and Medical Devices Agency. Relief program [Internet]. Tokyo (JP): Pharmaceuticals and Medical Devices Agency, c2018 [cited 2018 Jan 10]. Available from: http://www.pmda.go.jp/about-pmda/outline/0001.html.
  8. Taiwan Drug Relief Program. Relief program [Internet]. Taipei city (TWN): Taiwan Drug Relief Program. c2018 [cited 2018 Jan 10]. Available from: http://www.tdrf.org.tw/en/01_about/abo_01_list.asp.
  9. Suh HK. Relief system for adverse drug reaction, nonbenefit items will be compensated for. [Internet]. Seoul (KR): Yonhapnews, c2018 [cited 2018 Jan 10]. Available from: http://www.yonhapnews.co.kr/bulletin/2017/12/30/0200000000AKR20171230023400017.HTML.
  10. Yoo SR. Current status and suggestions for relief system for adverse drug reaction. KPMA Brief 2016;10:6-14.
  11. Oh MH. Contribution for drug relief. Charging doctors and pharmacists is inappropriate. [Internet]. Seoul (KR) : Korean Hospital Association News, c2018 [2018 Jan 10]. Available from: http://www.khanews.com/news/articleView.html?idxno=133692.
  12. Maeda H, Kurokawa T. Involvement of anticancer drugs in the Relief system for adverse drug reactions in Japan. Jpn J Clin Oncol 2013;43:1273-1281. https://doi.org/10.1093/jjco/hyt146

Cited by

  1. Adverse drug reactions vol.62, pp.9, 2018, https://doi.org/10.5124/jkma.2019.62.9.472
  2. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008–2017 vol.35, pp.4, 2018, https://doi.org/10.3346/jkms.2020.35.e17
  3. A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers vol.20, pp.1, 2018, https://doi.org/10.1186/s12889-020-09635-z